MassDevice Q&A

June 30, 2009 by MassDevice staff

Q&A Features

11/22/2010 by Christian Holland

MassDevice speaks with GE Healthcare's eHealth vice president Earl Jones on how information transparency might help control the healthcare costs, improve outcomes and dishes on the politics of healthcare IT.

MassDevice Podcast: GE Healthcare's Earl Jones

The term "liberated information" may sound like it was taken from a science fiction novel, but to General Electric's (NYSE:GE) Earl Jones, it's a means to improve access and quality to healthcare while at the same time making it cheaper. Jones is the vice president and general manager of the eHealth division of GE Healthcare, overseeing the development of information technology platforms that customers ranging from small doctors' offices to state governments are implementing into their everyday operations....

11/11/2010 by Brian Johnson

Dr. Thomas Fogarty, the founder of the Fogarty Institute for Innovation, discusses the investment climate for medical innovation, venture capital and explains why his passion for winemaking is actually an extension of his medical career.

MassDevice Podcast: Medical device legend Dr. Tom Fogarty

The man Stanford University once dubbed "The Mickey Mantle of medical device inventors" still has his swing, or at least his sway in the industry, judging by the reaction Dr. Thomas Fogarty received in Boston recently at a round-table discussion of medical device innovation.

Fogarty is a renowned cardiologist and serial inventor with more than 100 surgical patents to his name, including the Fogarty balloon catheter, his first and best-known contribution. In Boston, the 76-year-old could barely find time to break away from well-wishers...

11/02/2010 by Brian Johnson

William Hawkins, chairman and CEO of Medtronic Inc., dishes on mergers and acquisitions, the Food & Drug Administration and healthcare reform.

MassDevice Podcast: Medtronic CEO William Hawkins

For William Hawkins, Medtronic Inc. (NYSE:MDT) runs in the family.

Inside his corner office at the Fridley, Minn.-based medical device goliath, Hawkins, chairman and CEO of one of the world's largest medical device companies, keeps a picture of two customers he says not only shaped how he sees his company but how he sees the world.

One is Hawkins' father, who has had multiple Medtronic stents implanted. The the other is of his late uncle, a World War II veteran and Parkinson's disease sufferer who underwent deep brain stimulation therapy at the age of 87. It...

10/18/2010 by Brian Johnson

Listen to MassDevice.com's podcast with InfraReDx CEO Dr. James Muller, as he discusses the difficulty of finding financial backers to believe in his technology, the technology behind the IVUS "vulnerable plaque" imaging device and how innovative medical technologies can help drive down the cost of healthcare.

MassDevice Podcast: InfraReDx CEO Dr. James Muller

InfraReDx Inc. is on a roll this fall. The Burlington, Mass.-based medical device maker won 510(k) clearance from the Food...

08/23/2010 by Christian Holland

Absorption Systems CEO Patrick Dentinger dishes on growing a contract research organization amidst a recession and parlaying his drug testing business into the medical device development arena.

MassDevice Q&A: Absorption Systems CEO Patrick Dentinger

Absorption Systems LP is well-positioned in several sense of the word. The Exton, Pa. and San Diego-based contract research organization managed to expand during the Great Recession, buying medical device toxicology firm Perry Scientific last summer.

President and CEO Patrick Dentinger told MassDevice that his 100-employee firm, which profiles the absorption of pharmaceuticals into the human body before the drugs go to clinical testing, has barely had to paddle to catch a growing wave of...

08/16/2010 by Brad Perriello

Euan Thomson, president and CEO of Accuray Inc., on how his company managed to fare well despite the capital expenditure market's downturn, its distribution and R&D deal with Siemens and why healthcare reform could have a big upside for Accuray.

MassDevice Q&A: Accuray president and CEO Euan Thomson

Accuray Inc. (NSDQ:ARAY) has a tough row to hoe: Cultivate a market that crosses medical specialty lines for a product that costs millions. The Sunnyvale, Calif.-based company's CyberKnife system is a pioneering device in radiosurgery, using precisely targeted, massive doses of X-ray radiation to non-invasively destroy tumors.

Founded in the 1990, Accuray's device was based on an idea developed by a team of physicians at Stanford University, led by Dr. John Adler, in the late 1980s. Since its founding the company has seen its share of ups and downs, not least...

Syndicate content
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp